Deleted Tweets From Scott Gottlieb, R-D.C.

My comments on #FDA’s updated activities aimed at stemming the abuse of loperamide while maintaining access for appropriate patients who rely on this medicine https://t.co/emjI4SKBf6

We’re aware that those suffering from opioid addiction see loperamide as a potential alternative to manage opioid withdrawal symptoms or to achieve euphoric effects. But at very high doses, this drug is dangerous and #FDA must address abuse/misuse issues:

My comments on the new regulations that #FDA intends to pursue as part of the Administration’s unified agenda, which was released today https://t.co/Ixfg54Nwa4

RT @NCCNnews: Join us next month to hear what @SGottliebFDA and others have to say about the "New Normal" in Health Care >>… https://t.co/lczkSO1cJq

As with other new patterns of abuse and misuse related to the opioid crisis, #FDA acted with urgency to address the issues related to loperamide by revising labeling, encouraging packaging changes and asking online sellers to stop selling large quantities

RT @BioCentury: FDA planning guidance on designations for tissue agnostic therapies https://t.co/I2uLLBOuAv

Today @TheJusticeDept and #FDA filed complaints against two stem cell clinics for disregarding the law and more importantly, patient safety. We cannot allow unproven products that exploit the hope of patients and their loved ones. https://t.co/Aa7KFjZSl3

The complaints are seeking permanent injunctions to stop the two stem cell clinics from marketing stem cell products without @US_FDA approval and to halt their significant deviations from current good manufacturing practice requirements. https://t.co/Aa7K

RT @rickberke: Most aggressive crackdown on stem cell clinics in years. https://t.co/UpU11B9CO6 QT @DrewQJoseph: In significant action from @US_FDA today, agency moves to stop stem cell treatments at 2 notorious clinics. Agency… https://t.co/TDee6uNAFd)

#FDA will continue to take enforcement actions against stem cell clinics that abuse the trust of patients and endanger their health. https://t.co/Aa7KFjZSl3

RT @NYTHealth: The FDA moves to stop Florida and California stem cell clinics from marketing therapies that are not approved. https://t.co/OaMRgWh6dp

As part of our comprehensive plan for cell based regenerative medicine released earlier this year; #FDA framed a flexible, efficient framework by which cell treatments that are more than minimally manipulated and meet the definition of being drugs could g

Cell-based regenerative medicine holds significant opportunity, but we’ve seen some bad actors leverage the promise of this field to peddle unapproved treatments that put patients’ health at risk, in some instances, causing serious and permanent harm. htt

RT @FDAOncology: #PatientReportedOutcomes in regulatory decision making in the US, Europe and Canada #OCEPFDD https://t.co/8Rr3kcUxLM

#FDA experts are looking through thousands of records in this traceback investigation to try to identify a common way this lettuce got contaminated: https://t.co/We02xgGjGj

#FDA, CDC and partners continue to work hard to identify the source of the E. coli outbreak linked to romaine. Read CDC ‘s updated case information: https://t.co/We02xgGjGj

Romaine lettuce isn’t being distributed from the Yuma growing region so the potential for additional exposure to contaminated product is diminished. #FDA and CDC’s advice remains to not eat romaine lettuce from the Yuma growing region: https://t.co/We02xg

New warnings to stop misleading kids and other recent actions are just the opening salvo in a sustained campaign under #FDA’s Youth Tobacco Prevention Plan to address all aspects of youth access/appeal of tobacco products, and in particular, e-cigarettes:

https://t.co/9TwrU7Ef6N

RT @US_FDA: “Companies putting children at risk or enticing youth use are on notice. If you target kids, then we’re going to ta… https://t.co/9IuAHe0n4v

My comments on #FDA’s updated activities aimed at stemming the abuse of loperamide while maintaining access for appropriate patients who rely on this medicine https://t.co/emjI4SKBf6

We’re aware that those suffering from opioid addiction see loperamide as a potential alternative to manage opioid withdrawal symptoms or to achieve euphoric effects. But at very high doses, this drug is dangerous and #FDA must address abuse/misuse issues:

My comments on the new regulations that #FDA intends to pursue as part of the Administration’s unified agenda, which was released today https://t.co/Ixfg54Nwa4

RT @NCCNnews: Join us next month to hear what @SGottliebFDA and others have to say about the "New Normal" in Health Care >>… https://t.co/lczkSO1cJq

As with other new patterns of abuse and misuse related to the opioid crisis, #FDA acted with urgency to address the issues related to loperamide by revising labeling, encouraging packaging changes and asking online sellers to stop selling large quantities

RT @BioCentury: FDA planning guidance on designations for tissue agnostic therapies https://t.co/I2uLLBOuAv

Today @TheJusticeDept and #FDA filed complaints against two stem cell clinics for disregarding the law and more importantly, patient safety. We cannot allow unproven products that exploit the hope of patients and their loved ones. https://t.co/Aa7KFjZSl3

The complaints are seeking permanent injunctions to stop the two stem cell clinics from marketing stem cell products without @US_FDA approval and to halt their significant deviations from current good manufacturing practice requirements. https://t.co/Aa7K

RT @rickberke: Most aggressive crackdown on stem cell clinics in years. https://t.co/UpU11B9CO6 QT @DrewQJoseph: In significant action from @US_FDA today, agency moves to stop stem cell treatments at 2 notorious clinics. Agency… https://t.co/TDee6uNAFd)

#FDA will continue to take enforcement actions against stem cell clinics that abuse the trust of patients and endanger their health. https://t.co/Aa7KFjZSl3

RT @NYTHealth: The FDA moves to stop Florida and California stem cell clinics from marketing therapies that are not approved. https://t.co/OaMRgWh6dp

As part of our comprehensive plan for cell based regenerative medicine released earlier this year; #FDA framed a flexible, efficient framework by which cell treatments that are more than minimally manipulated and meet the definition of being drugs could g

Cell-based regenerative medicine holds significant opportunity, but we’ve seen some bad actors leverage the promise of this field to peddle unapproved treatments that put patients’ health at risk, in some instances, causing serious and permanent harm. htt

RT @FDAOncology: #PatientReportedOutcomes in regulatory decision making in the US, Europe and Canada #OCEPFDD https://t.co/8Rr3kcUxLM

#FDA experts are looking through thousands of records in this traceback investigation to try to identify a common way this lettuce got contaminated: https://t.co/We02xgGjGj

#FDA, CDC and partners continue to work hard to identify the source of the E. coli outbreak linked to romaine. Read CDC ‘s updated case information: https://t.co/We02xgGjGj

Romaine lettuce isn’t being distributed from the Yuma growing region so the potential for additional exposure to contaminated product is diminished. #FDA and CDC’s advice remains to not eat romaine lettuce from the Yuma growing region: https://t.co/We02xg

New warnings to stop misleading kids and other recent actions are just the opening salvo in a sustained campaign under #FDA’s Youth Tobacco Prevention Plan to address all aspects of youth access/appeal of tobacco products, and in particular, e-cigarettes:

https://t.co/9TwrU7Ef6N

RT @US_FDA: “Companies putting children at risk or enticing youth use are on notice. If you target kids, then we’re going to ta… https://t.co/9IuAHe0n4v